These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7828134)

  • 1. Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancer.
    Solé LA; Albanell J; Bellmunt J; Ribas A; Gallego OS; Carulla J
    Cancer; 1995 Feb; 75(3):831-5. PubMed ID: 7828134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of oral tegafur and folinic acid with mitoxantrone as first-line regimen in patients with metastatic breast cancer.
    Alonso V; Santader C; Florian J; Alonso M; Isla MD; Escudero P; Saenz A; Tres A
    Tumori; 1996; 82(1):61-4. PubMed ID: 8623508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience.
    Lin JK; Wang WS; Hsieh RK; Hsu TC; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Jpn J Clin Oncol; 2000 Nov; 30(11):510-4. PubMed ID: 11155922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.
    Pazdur R; Lassere Y; Rhodes V; Ajani JA; Sugarman SM; Patt YZ; Jones DV; Markowitz AB; Abbruzzese JL; Bready B
    J Clin Oncol; 1994 Nov; 12(11):2296-300. PubMed ID: 7964943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of uracil-ftorafur, leucovorin, and etoposide: an active all-oral regimen for metastatic breast cancer.
    Hartman AR; Grekowicz A; Lum BL; Carlson RW; Schurman C; Sikic BI; Shapiro R; Stockdale FE
    Breast Cancer Res Treat; 2003 Nov; 82(1):61-9. PubMed ID: 14672404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
    Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.
    Feliu J; González Barón M; Espinosa E; García Girón C; de la Gándara I; Espinosa J; Colmenarejo A; Jalón JI; Fernández Y; de Castro J
    Cancer; 1997 May; 79(10):1884-9. PubMed ID: 9149013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
    Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I - II study of oral idarubicin, tegafur and levo-folinate in patients with pretreated advanced breast cancer.
    Cilenti G; Tozzi L; Suriano A; Tartarone A; Lelli G
    J Chemother; 1999 Oct; 11(5):402-6. PubMed ID: 10632388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I study of UFT-oral vinorelbine in metastatic breast cancer.
    Ferrero JM; Largillier R; Michel C; Amiot V; Milano G; Hébert C; Mari V; Courdi A; Figl A; Follana P; Barrière J; Chamorey E
    Oncology; 2011; 81(2):73-8. PubMed ID: 21968516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancer.
    Fine S; Erlichman C; Kaizer L; Warr D; Gadalla T
    Breast Cancer Res Treat; 1994; 30(2):205-9. PubMed ID: 7949219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of paclitaxel and uracil--tegafur in metastatic breast cancer. TEGATAX trial.
    Villanueva C; Chaigneau L; Dufresne A; Thierry Vuillemin A; Stein U; Demarchi M; Bazan F; N'guyen T; Pivot X
    Breast; 2011 Aug; 20(4):329-33. PubMed ID: 21439823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
    Klaassen U; Harstrick A; Wilke H; Seeber S
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary report of a phase II trial. UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Spanish Group for the Treatment of Gastrointestinal Tumors (TTd Group).
    Abad A; Navarro M; Sastre J; Marcuello E; Aranda E; Gallén M; Fernandez-Martos C; Martín C; Diaz-Rubio E
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):53-7. PubMed ID: 9348570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma.
    Nogué M; Seguí MA; Saigí E; Batiste-Alentorn E; Arcusa A; Boleda M; Antón I
    Cancer; 1998 Jul; 83(2):254-8. PubMed ID: 9669807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer.
    Kim DJ; Kim TI; Suh JH; Cho YS; Shin SK; Kang JK; Kim NK; Kim WH
    Yonsei Med J; 2003 Aug; 44(4):665-75. PubMed ID: 12950123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial. Oral UFT and leucovorin in patients with advanced gastric carcinoma.
    Kim YH; Shin SW; Kim BS; Park YT; Kim JG; Kim JS
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):119-23. PubMed ID: 9348583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.